Global Peripheral Artery Disease Devices Market Size, Share, Analysis Report - Forecast 2032

Peripheral Artery Disease Devices Market Insights

According to Market Research Store, the global peripheral artery disease devices market size was valued at around USD 4.82 billion in 2023 and is estimated to reach USD 10.60 billion by 2032, to register a CAGR of approximately 8.2% in terms of revenue during the forecast period 2024-2032.

The peripheral artery disease devices report provides a comprehensive analysis of the market, including its size, share, growth trends, revenue details, and other crucial information regarding the target market. It also covers the drivers, restraints, opportunities, and challenges till 2032.

To Get more Insights, Request a Free Sample

Peripheral Artery Disease Devices Market: Overview

The Peripheral Artery Disease (PAD) Devices market is experiencing significant growth, driven by the increasing prevalence of PAD, advancements in minimally invasive vascular treatments, and rising demand for effective endovascular therapies. PAD is a circulatory condition characterized by narrowed arteries reducing blood flow to the limbs, primarily due to atherosclerosis. Peripheral artery disease devices, including angioplasty balloons, stents, atherectomy devices, and chronic total occlusion (CTO) devices, are widely used for the diagnosis and treatment of PAD, improving blood circulation and reducing the risk of complications such as critical limb ischemia (CLI) and amputation.

Market expansion is fueled by the growing aging population, increasing incidence of diabetes and hypertension, and rising awareness of PAD symptoms and treatment options. The shift toward minimally invasive procedures has driven the adoption of drug-coated balloons (DCBs) and bioresorbable stents, which offer improved long-term outcomes compared to traditional treatment methods. Additionally, technological advancements, including image-guided interventions and AI-driven diagnostic tools, are enhancing treatment precision and patient outcomes.

 Key Highlights

• The peripheral artery disease devices market is anticipated to grow at a CAGR of 8.2% during the forecast period.
• The global peripheral artery disease devices market was estimated to be worth approximately USD 4.82 billion in 2023 and is projected to reach a value of USD 10.60 billion by 2032.
• The growth of the peripheral artery disease devices market is being driven by the increasing prevalence of PAD due to factors such as aging populations, rising rates of diabetes, and sedentary lifestyles.
• Based on the product, the peripheral angioplasty balloons segment is growing at a high rate and is projected to dominate the market.
• On the basis of treatment, the device segment is projected to swipe the largest market share.
• In terms of disease, the lipid lowering drugs segment is expected to dominate the market.
• Based on the end user, the hospitals & clinics segment is expected to dominate the market.
• By region, North America is expected to dominate the global market during the forecast period.

Peripheral Artery Disease Devices Market: Dynamics

Key Drivers

• Increasing Prevalence of PAD: The rising prevalence of PAD, driven by factors like aging populations, diabetes, and lifestyle choices, is a major driver.
• Growing Awareness and Diagnosis: Increased awareness of PAD and improved diagnostic techniques are leading to earlier detection and treatment, driving demand for devices.
• Minimally Invasive Procedures: The preference for minimally invasive procedures over traditional open surgery is a significant driver, as PAD devices enable less invasive interventions.
• Technological Advancements: Continuous advancements in device technology, such as improved stent designs, atherectomy devices, and drug-coated balloons, are enhancing treatment outcomes and expanding the scope of interventions.
• Aging Population with Comorbidities: The aging population often has comorbidities like diabetes, which increases the likelihood of PAD, and the need for medical devices to treat it.

Restraints

• High Cost of Devices: Advanced PAD devices can be expensive, which can limit their accessibility, particularly in resource-constrained healthcare settings.
• Risk of Complications: PAD interventions, like any medical procedure, carry risks, including restenosis, thrombosis, and embolization, which can limit adoption.
• Limited Reimbursement: Reimbursement policies for PAD procedures and devices can vary, which can impact adoption rates.
• Need for Skilled Professionals: PAD interventions require skilled interventional cardiologists and radiologists, which can limit access to these procedures in some regions.

Opportunities

• Development of Drug-Eluting Devices: Continued development of drug-eluting stents and balloons to reduce restenosis and improve long-term outcomes.
• Focus on Below-the-Knee (BTK) Interventions: The growing need for effective treatments for critical limb ischemia (CLI) and BTK lesions presents significant opportunities for device manufacturers.
• Integration of Imaging Technologies: Integrating advanced imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), with PAD devices can improve procedural guidance and outcomes.
• Remote Monitoring and Telemedicine: The growing use of remote monitoring and telemedicine can improve patient management and follow-up after PAD interventions.
• Personalized Medicine Approaches: Developing PAD devices and therapies tailored to individual patient needs and risk factors can improve treatment efficacy.

Challenges

• Addressing Restenosis: Restenosis remains a significant challenge in PAD interventions, requiring ongoing research and development of more effective devices and therapies.
• Managing Complex Lesions: Treating complex PAD lesions, such as calcified lesions and long-segment occlusions, requires advanced devices and techniques.
• Ensuring Long-Term Patency: Achieving long-term patency of treated vessels is crucial for improving patient outcomes and quality of life.
• Navigating Regulatory Pathways: Obtaining regulatory approvals for new PAD devices can be a complex and time-consuming process.
• Demonstrating Clinical Efficacy: Robust clinical evidence is essential for demonstrating the safety and efficacy of new PAD devices and therapies.

Peripheral Artery Disease Devices Market: Report Scope

This report thoroughly analyzes the Peripheral Artery Disease Devices Market, exploring its historical trends, current state, and future projections. The market estimates presented result from a robust research methodology, incorporating primary research, secondary sources, and expert opinions. These estimates are influenced by the prevailing market dynamics as well as key economic, social, and political factors. Furthermore, the report considers the impact of regulations, government expenditures, and advancements in research and development on the market. Both positive and negative shifts are evaluated to ensure a comprehensive and accurate market outlook.

Peripheral Artery Disease Devices Market: Segmentation Insights

The global peripheral artery disease devices market is divided by product, treatment, disease, end user, and region.

Segmentation Insights by Product

Based on product, the global peripheral artery disease devices market is divided into peripheral angioplasty balloons, plaque modification devices, peripheral stents, peripheral catheters, hemodynamic flow alteration devices, inferior vena cava (IVC) filters, and peripheral accessories.

The Peripheral Angioplasty Balloons segment dominates the Peripheral Artery Disease (PAD) Devices Market due to its widespread adoption in minimally invasive procedures for treating arterial blockages. These balloons are crucial in percutaneous transluminal angioplasty (PTA), which helps restore blood flow in narrowed or occluded arteries. The increasing prevalence of PAD, coupled with the rising preference for balloon angioplasty over traditional surgical interventions, has fueled market growth. Additionally, advancements in drug-coated balloons (DCBs) have further enhanced treatment efficacy by reducing restenosis rates and improving patient outcomes.

The Plaque Modification Devices segment plays a significant role in the market, particularly in cases involving heavily calcified plaques. Devices such as atherectomy systems and laser ablation tools are utilized to remove plaque buildup before angioplasty or stenting, ensuring optimal vessel dilation. The demand for these devices is increasing as interventional cardiologists seek more effective solutions for complex PAD cases.

The Peripheral Stents segment is another key contributor, particularly with the rising adoption of drug-eluting and bioresorbable stents. These stents provide long-term support to treated arteries, preventing re-narrowing and improving blood flow. The shift toward next-generation stents with improved flexibility and durability is driving growth in this segment.

The Peripheral Catheters market is expanding due to the increasing use of guidewires, aspiration catheters, and support catheters in PAD procedures. These devices play a crucial role in navigating complex lesions and ensuring successful interventions. Innovations in catheter technology, including hydrophilic coatings and enhanced trackability, are further boosting demand.

The Hemodynamic Flow Alteration Devices segment, which includes embolic protection devices and chronic total occlusion (CTO) revascularization devices, is witnessing growth due to the rising complexity of PAD cases. These devices help manage embolic debris and improve procedural safety during interventions.

The Inferior Vena Cava (IVC) Filters segment is primarily used in cases where patients are at high risk of pulmonary embolism (PE). These filters are deployed in patients who cannot undergo anticoagulation therapy, helping prevent life-threatening complications.

The Peripheral Accessories segment, including guidewires, introducer sheaths, and inflation devices, supports various PAD procedures. The rising number of endovascular interventions and the growing need for advanced accessory tools are contributing to segment expansion.

Segmentation Insights by Treatment

On the basis of treatment, the global peripheral artery disease devices market is bifurcated into device, catheters, plaque modification devices, hemodynamic flow alteration devices, and others.

The Device segment dominates the Peripheral Artery Disease (PAD) Devices Market due to the increasing adoption of minimally invasive treatment options and advancements in medical technology. Devices such as angioplasty balloons, stents, and drug-coated balloons are widely used in revascularization procedures to restore proper blood circulation in narrowed arteries. The rising prevalence of PAD, coupled with a growing preference for non-surgical interventions, has fueled the demand for these devices. Additionally, improvements in stent design and drug-eluting technologies have enhanced procedural outcomes, reducing restenosis rates and the need for repeat interventions.

The Catheters segment plays a crucial role in PAD treatment, particularly in delivering therapeutic agents, guiding interventions, and ensuring precise navigation within blocked arteries. Diagnostic and therapeutic catheters are integral to minimally invasive procedures, with advancements in hydrophilic coatings and flexible designs enhancing procedural success. The increasing number of catheter-based interventions for PAD treatment is driving market growth in this segment.

The Plaque Modification Devices segment, including atherectomy systems and laser ablation tools, is gaining traction due to the need for effective plaque removal in complex PAD cases. These devices are particularly useful in treating heavily calcified or long-segment lesions where conventional balloon angioplasty may be less effective. The rising adoption of atherectomy techniques in combination with drug-coated balloons is improving long-term patient outcomes and expanding the segment's market share.

The Hemodynamic Flow Alteration Devices segment, which includes embolic protection devices and chronic total occlusion (CTO) revascularization tools, is witnessing increased adoption due to its ability to improve procedural safety. These devices help minimize the risk of embolization during interventions, ensuring better patient outcomes and reducing complications such as distal embolization. The growing number of complex PAD cases has led to a higher demand for advanced hemodynamic management solutions.

Segmentation Insights by Disease

On the basis of disease, the global peripheral artery disease devices market is bifurcated into lipid lowering drugs, triple-h therapy, glucose regulating drugs, blood clot preventing drugs, inotropes, thrombolytic agents, and anti-inflammatory agents.

The Lipid Lowering Drugs segment dominates the Peripheral Artery Disease (PAD) Devices Market due to the high prevalence of atherosclerosis, a major cause of PAD. Statins and other lipid-lowering medications play a critical role in reducing cholesterol levels and slowing plaque buildup in arteries, thereby improving blood flow and reducing the risk of cardiovascular complications. With increasing awareness of PAD management and the widespread prescription of statins, this segment continues to hold a strong market position.

The Triple-H Therapy segment, which involves hemodilution, hypertension, and hypervolemia management, is gaining importance in preventing ischemic complications in PAD patients. This therapy is particularly used in critical limb ischemia cases where maintaining adequate blood flow is essential. The growing adoption of combination therapies in PAD management is driving segment growth.

The Glucose Regulating Drugs segment is expanding due to the strong link between diabetes and PAD. Medications such as metformin, SGLT2 inhibitors, and GLP-1 receptor agonists help regulate blood sugar levels, reducing the risk of vascular complications. With a rising global diabetic population, the demand for glucose-regulating drugs for PAD patients is increasing.

The Blood Clot Preventing Drugs segment, including antiplatelet and anticoagulant therapies, is crucial in preventing clot formation and reducing the risk of critical ischemic events in PAD patients. Drugs such as aspirin, clopidogrel, and novel oral anticoagulants (NOACs) are widely prescribed to prevent thrombosis and improve vascular health, driving strong market growth in this category.

The Inotropes segment, which includes drugs that enhance heart contractility, is primarily used in patients with severe PAD and heart failure. These medications help maintain adequate perfusion and support cardiovascular function, particularly in high-risk patients. Although a smaller segment, its significance is growing with increasing cases of PAD-related complications.

The Thrombolytic Agents segment is critical for acute limb ischemia treatment, as these drugs help dissolve blood clots and restore blood flow in blocked arteries. Drugs such as alteplase and reteplase are used in emergency settings to prevent limb loss, making this an essential component of PAD management.

The Anti-Inflammatory Agents segment is emerging as a key area of interest due to the role of inflammation in PAD progression. Medications targeting inflammatory pathways, such as colchicine and IL-6 inhibitors, are being explored for their potential in improving long-term PAD outcomes. The segment is expected to witness increased research and development activity in the coming years.

Segmentation Insights by End User

On the basis of end user, the global peripheral artery disease devices market is bifurcated into hospitals & clinics, and ambulatory surgical clinics.

The Hospitals & Clinics segment dominates the Peripheral Artery Disease (PAD) Devices Market due to the high volume of PAD diagnoses, advanced treatment options, and availability of specialized vascular care. Hospitals and clinics serve as the primary treatment centers for PAD patients, offering comprehensive diagnostic imaging, catheter-based interventions, and surgical procedures. The increasing prevalence of PAD, coupled with the rising adoption of minimally invasive endovascular treatments, is driving demand for peripheral stents, angioplasty balloons, and plaque modification devices in hospital settings. Additionally, hospitals and clinics provide post-procedural care and long-term disease management, further strengthening their position in the market.

The Ambulatory Surgical Clinics segment is experiencing significant growth, fueled by the increasing preference for outpatient procedures and cost-effective treatment alternatives. These clinics specialize in minimally invasive interventions, including peripheral angioplasty and catheter-based therapies, allowing patients to receive treatment without extended hospital stays. The shift toward outpatient vascular care, advancements in PAD device technology, and favorable reimbursement policies are contributing to the expansion of this segment. With rising demand for same-day procedures and improved patient convenience, ambulatory surgical clinics are emerging as an important segment in the PAD devices market.

Peripheral Artery Disease Devices Market: Regional Insights

• North America is expected to dominates the global market

North America dominates the Peripheral Artery Disease Devices Market due to the high prevalence of PAD, advanced healthcare infrastructure, and the strong presence of key market players. The United States is the leading market, with a growing aging population and increasing incidence of PAD due to high obesity and diabetes rates. The demand for minimally invasive treatment options, such as drug-coated balloons and atherectomy devices, is rising, supported by favorable reimbursement policies and technological advancements. Canada also exhibits a steady market growth due to increasing healthcare investments and improving access to PAD treatment options. The region benefits from extensive clinical research and regulatory approvals for innovative endovascular devices.

Europe holds a significant share in the market, driven by a rising number of PAD cases, increasing awareness about early diagnosis, and advancements in vascular treatments. Germany, the UK, and France are key markets. Germany’s well-established healthcare sector and high adoption of endovascular interventions contribute to strong market demand. The UK is witnessing increasing adoption of stents and drug-coated balloons for PAD treatment, supported by government initiatives to improve cardiovascular health. France, with its strong focus on minimally invasive procedures and advanced hospital infrastructure, is also a major contributor. The European Union’s regulatory framework encourages innovation, while reimbursement policies for PAD treatment further support market growth.

Asia Pacific is the fastest-growing region in the Peripheral Artery Disease Devices Market, fueled by a rising geriatric population, increasing prevalence of diabetes and hypertension, and improving healthcare infrastructure. China, India, Japan, and South Korea are key markets. China’s growing healthcare investments and increasing demand for vascular interventions are driving market expansion. India, with a rapidly increasing diabetic population, is witnessing a surge in demand for affordable PAD treatment options. Japan and South Korea, known for their advanced medical technology adoption, are investing in cutting-edge endovascular treatments and expanding access to minimally invasive procedures. The increasing awareness of PAD symptoms and early diagnosis in the region is also contributing to market growth.

Latin America is experiencing steady market growth, with Brazil and Mexico leading the adoption of PAD treatment devices. The region’s increasing burden of cardiovascular diseases and government efforts to improve vascular healthcare are driving market expansion. Brazil’s healthcare sector is adopting more minimally invasive PAD treatments, while Mexico’s rising awareness of PAD-related complications is boosting demand for diagnostic and therapeutic devices. However, economic constraints and limited access to advanced healthcare technologies in some areas may restrict rapid market penetration.

The Middle East & Africa is seeing rising adoption of PAD treatment devices, particularly in the UAE, Saudi Arabia, and South Africa. The increasing prevalence of diabetes and cardiovascular diseases, coupled with improving healthcare facilities, is driving market growth. Saudi Arabia’s healthcare modernization under Vision 2030 and the UAE’s investments in advanced medical technologies are contributing to demand. South Africa, with its growing burden of non-communicable diseases, is witnessing increasing adoption of PAD treatment solutions. However, limited access to specialized vascular care in certain regions may slow market growth.

Peripheral Artery Disease Devices Market: Competitive Landscape

The report provides an in-depth analysis of companies operating in the peripheral artery disease devices market, including their geographic presence, business strategies, product offerings, market share, and recent developments. This analysis helps to understand market competition.

Some of the major players in the global peripheral artery disease devices market include:

• Abbott Laboratories
• AngioDynamics
• B. Braun Melsungen
• BIOTRONIK
• Boston Scientific
• C. R. Bard
• Cardinal Health
• Cook Medical
• Medtronic
• Terumo
• The Spectranetics

The global peripheral artery disease devices market is segmented as follows:

By Product

• Peripheral Angioplasty Balloons
• Plaque Modification Devices
• Peripheral Stents
• Peripheral Catheters
• Hemodynamic Flow Alteration Devices
• Inferior Vena Cava (IVC) Filters
• Peripheral Accessories

By Treatment

• Device
• Catheters
• Plaque Modification Devices
• Hemodynamic Flow Alteration Devices
• Others

By Disease

• Lipid Lowering Drugs
• Triple-H Therapy
• Glucose Regulating Drugs
• Blood Clot Preventing Drugs,
• Inotropes,
• Thrombolytic Agents,
• Anti-Inflammatory Agents

By End User

• Hospitals & Clinics
• Ambulatory Surgical Clinics

By Region

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • France
  • Germany
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• The Middle East and Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East Africa

Frequently Asked Questions